Subscribe in a reader

Cambridge MedChem Consulting

16th RSC-SCI Medicinal Chemistry Symposium

The first circular for the 16th RSC-SCI Medicinal Chemistry Symposium, 11-14 September 2011, Churchill College, Cambridge, UK is now available here.

Scientifc Program includes:-

  • Strategies to success - H-PGDS inhibitors for the treatment of inflamatory disorders, Sukanthini Thurauratnam, Sanofi -Aventis

  • Discovery on next generation glucokinase activators, Mike Waring, AstraZeneca

  • Inhalation by design, Paul Glosson, Pfizer

  • Bromodomains a new class of epigenetic targets for small molecule drug discovery, Jason Witherington, GSK

  • GPCR Structure based drug design using stabilised receptors(StaRs), Miles Congreve, Heptares

  • GS-9350: a novel pharmacoenhancer, Lianhong Xu, Gilead Sciences